Novo CEO Doustdar to Pfizer on Metsera Takeover Battle: ‘Bid Higher’
PositiveFinancial Markets

Novo CEO Doustdar to Pfizer on Metsera Takeover Battle: ‘Bid Higher’
Novo Nordisk is stepping up its game in the competitive takeover battle for Metsera, an obesity startup, by increasing its offer once again. CEO Mike Doustdar made headlines during a press conference at the White House, urging Pfizer to raise their bid. This move not only highlights Novo's commitment to expanding its portfolio in the obesity treatment market but also signals the growing importance of innovative solutions in healthcare. The outcome of this battle could significantly impact the future of obesity treatments.
— via World Pulse Now AI Editorial System







